| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 41 |
| 1 | MACITENTAN | 28 |
| 2 | SILDENAFIL CITRATE | 20 |
| 3 | TREPROSTINIL | 19 |
| 4 | TADALAFIL | 18 |
| 5 | AMBRISENTAN | 14 |
| 6 | SILDENAFIL | 13 |
| 7 | FUROSEMIDE | 12 |
| 8 | 0XYGEN | 10 |
| 9 | OXYGEN | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 41 | 0.0038 |
| 1 | OXACILLIN SODIUM | 1 | 0.0012 |
| 2 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0007 |
| 3 | EPOPROSTENOL SODIUM | 5 | 0.0007 |
| 4 | MACITENTAN | 28 | 0.0006 |
| 5 | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0006 |
| 6 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 1 | 0.0006 |
| 7 | RIOCIGUAT | 10 | 0.0005 |
| 8 | 0XYGEN | 10 | 0.0004 |
| 9 | OXYGEN | 10 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 56 | 0.0006 |
| 1 | Soluble Guanylate Cyclase Stimulator [EPC] | 10 | 0.0005 |
| 2 | Endothelin Receptor Antagonist [EPC] | 39 | 0.0003 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 24 | 0.0002 |
| 4 | Prostacyclin Receptor Agonist [EPC] | 4 | 0.0002 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Thiazide-like Diuretic [EPC] | 3 | 0.0001 |
| 7 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 8 | Cardiac Glycoside [EPC] | 5 | 0.0001 |
| 9 | Aldosterone Antagonist [EPC] | 7 | 0.0001 |